Search - tctmd.com

Displaying 361 - 380 of 752

Sort: Relevancy | Date

News Daily News

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

December 14, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

December 14, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

December 10, 2015

News Daily News

Las Sociedades Publican Recomendaciones para que Operadores y Centros Ofrezcan Intervenciones para el Cierre del AAI

December 10, 2015

News Daily News

Path to Top FDA Post Gets a Bit Rockier for Califf

Michael O'Riordan

December 09, 2015

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-term Warfarin

Presentation

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-term Warfarin

Presenter: Matthew J. Price

November 29, 2015

News Daily News

Does the Watchman LAA Occluder Reduce Bleeding?

November 25, 2015

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Daily News

Good News, Bad News Week for Watchman LAA Occluder

November 12, 2015

News Conference News AHA 2015

Is Watchman Cost-effective? That Depends Where You Look

November 07, 2015

News Daily News

首个 NOAC 逆转剂 Idarucizumab 获批；不太可能耽误介入治疗

October 26, 2015

News Daily News

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

October 26, 2015

News Daily News

Aprobado el Idarucizumab, Primer Antídoto de NOAC; El Deseo es no Demorar las Intervenciones

October 26, 2015

News Conference News TCT 2015

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

October 15, 2015

TCT 57: A Cost Analysis of Bleed Complications From 2 Stroke Prevention Strategies in Nonvalvular Atrial Fibrillation: Left Atrial Appendage Closure Versus Warfarin

Presentation TCT 2015

TCT 57: A Cost Analysis of Bleed Complications From 2 Stroke Prevention Strategies in Nonvalvular Atrial Fibrillation: Left Atrial Appendage Closure Versus Warfarin

Presenter: Jacqueline Saw, Steven J. Yakubov, Matthew J. Price

October 13, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

October 11, 2015

News Industry News

Scripps experts present at 2015 TCT scientific symposium

October 09, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.